HomeInsightsStock Comparison

Aprameya Engineering Ltd vs Transgene Biotek Ltd Stock Comparison

Aprameya Engineering Ltd vs Transgene Biotek Ltd Stock Comparison

Last Updated on: Jun 29, 2025

Key Highlights

  • The Latest Trading Price of Aprameya Engineering Ltd is ₹ 167.95 as of 27 Jun 15:30.
  • The P/E Ratio of Aprameya Engineering Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Transgene Biotek Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Aprameya Engineering Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Transgene Biotek Ltd changed from ₹ 22.81 crore on March 2020 to ₹ 61.68 crore on March 2024 . This represents a CAGR of 22.01% over 5 years.
  • The revenue of Aprameya Engineering Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Transgene Biotek Ltd for the Mar '25 is ₹ 0.12 crore as compare to the Dec '24 revenue of ₹ 0.12 crore. This represent the decline of 0%.
  • The ebitda of Aprameya Engineering Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Transgene Biotek Ltd for the Mar '25 is ₹ -0.5 crore as compare to the Dec '24 ebitda of ₹ -0.05 crore. This represent the growth of 900%.
  • The net profit of Aprameya Engineering Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Transgene Biotek Ltd changed from ₹ -0.13 crore to ₹ -0.71 crore over 8 quarters. This represents a CAGR of 133.70% .
  • The Dividend Payout of Aprameya Engineering Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Transgene Biotek Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Aprameya Engineering Ltd

  • Aprameya Engineering Limited was originally formed as a Partnership Firm in the name and style of 'M/s.
  • Aprameya Engineering' pursuant to a Deed of Partnership dated September 05, 2003, registered as on August 13, 2004 at Ahmedabad.
  • Subsequently, Company incorporated pursuant to a Certificate of Incorporation dated December 28, 2021 issued by the Registrar of Companies, following the conversion of Partnership Firm 'M/s.
  • Aprameya Engineering' to a Private Limited Company.
  • Further, Company converted into a Public Limited Company and its name was changed from 'Aprameya Engineering Private Limited' to 'Aprameya Engineering Limited' vide a fresh Certificate of Incorporation upon conversion dated May 12, 2022, issued by the Registrar of Companies, Ahmedabad. The Company is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre, dialysis centres and prefabricated structure ward in the hospitals and medical care centres on turnkey basis along with supply of high value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals and medical practitioners.

About Transgene Biotek Ltd

  • Founded in March, 1990 by Dr. Koteswara Rao, Transgene Biotek Ltd was one of the first Biotechnology companies in India.
  • Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
  • The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

Aprameya Engineering Ltd News Hub

News

Aprameya Engineering to convene AGM

Aprameya Engineering announced that the Annual General Meeting(AGM) of the company will be...

Read more

09 May 2025 12:38

News

Aprameya Engineering announces board meeting date

Aprameya Engineering will hold a meeting of the Board of Directors of the Company on 8 May...

Read more

03 May 2025 10:52

News

Aprameya Engineering schedules board meeting

Aprameya Engineering will hold a meeting of the Board of Directors of the Company on 11 No...

Read more

07 Nov 2024 15:30

News

NSE SME Aprameya Engineering makes a strong debut

The scrip was listed at Rs 72, a premium of 24.14% over the initial public offer (IPO) pri...

Read more

01 Aug 2024 13:11

Transgene Biotek Ltd News Hub

News

Transgene Biotek announces board meeting date

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 7 May 202...

Read more

28 Apr 2025 09:22

News

Transgene Biotek declare Quarterly Result

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 24 Januar...

Read more

17 Jan 2025 11:58

News

Transgene Biotek to announce Quarterly Result

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 12 Novemb...

Read more

05 Nov 2024 12:01

News

Transgene Biotek to hold board meeting

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 10 August...

Read more

20 Jul 2024 12:06

News

Transgene Biotek schedules board meeting

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 30 May 20...

Read more

13 May 2024 11:11

News

Transgene Biotek to conduct board meeting

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 14 Februa...

Read more

30 Jan 2024 14:56

SWOT Analysis Of Transgene Biotek Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Aprameya Engineering Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Transgene Biotek Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Aprameya Engineering Ltd and Transgene Biotek Ltd

Which company has a larger market capitalization, Aprameya Engineering Ltd or Transgene Biotek Ltd?

Market cap of Aprameya Engineering Ltd is 319 Cr while Market cap of Transgene Biotek Ltd is 33 Cr

What are the key factors driving the stock performance of Aprameya Engineering Ltd and Transgene Biotek Ltd?

The stock performance of Aprameya Engineering Ltd and Transgene Biotek Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aprameya Engineering Ltd and Transgene Biotek Ltd?

As of June 29, 2025, the Aprameya Engineering Ltd stock price is INR ₹167.95. On the other hand, Transgene Biotek Ltd stock price is INR ₹4.42.

How do dividend payouts of Aprameya Engineering Ltd and Transgene Biotek Ltd compare?

To compare the dividend payouts of Aprameya Engineering Ltd and Transgene Biotek Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions